Spire's six most recent Spirethoughts.

Soybeans set to reap from global health movement
Global disruption of PPE supply chain
Demand for Masks is 10x production capacity
Asia’s demand for Air Purifiers increases as air quality worsens
APAC Silver Tsunami: Ageing Market worth US$4.56 trillion by 2025
Asian Flavours gain popularity

The Coronavirus spells trouble for the pharma industry in India and globally

The coronavirus has disrupted manufacturing in China and delivered a shock to global supply chains. One industry that is affected is pharmaceuticals.

China is a major production centre for active pharmaceutical ingredients or APIs.

Globally this has triggered concern. In India, pharma industry leaders have expressed concern that if disruption continues, pharma supply and prices would be affected. Market prices for anti-inflammatory drugs and antibiotics in India have risen sharply as a result of the crisis.

Will the coronavirus disrupt the global supply of pharmaceuticals?

For media enquiries, please contact:

Marie Teo
Manager, Group Marketing Communications
Spire Research and Consulting
Phone: (65) 6838 5355
E-mail: marie.teo@spireresearch.com

Back to Top

Back to Home